Nadela, Lovely .

HRN: 27-87-88  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/02/2025
AMPICILLIN 1GM (VIAL)
10/02/2025
10/09/2025
IVT
2g
Q6
Pprom
Waiting Final Action 
10/02/2025
CEFUROXIME 500MG (TAB)
10/02/2025
10/09/2025
IVT
500 Mg
BID
TMSAF
Waiting Final Action 
10/02/2025
METRONIDAZOLE 500MG (TAB)
10/02/2025
10/09/2025
IVT
500 MG
Tid
Tmsaf
Waiting Final Action 
10/07/2025
CEFUROXIME 500MG (TAB)
10/02/2025
10/09/2025
PO
500mg
Bid
Tmsaf
Waiting Final Action 
10/07/2025
METRONIDAZOLE 500MG (TAB)
10/02/2025
10/09/2025
PO
500mg
TID
Tmsaf
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: